title: Enhancement of thrombolysis by ultrasound.
abstract: Drug-induced early reperfusion in acute myocardial infarction reduces myocardial damage and decreases mortality. A further beneficial effect may be achieved if the time from start of thrombolytic treatment to reperfusion, on average 45 min, can be shortened. With this purpose in mind, we have analysed the effect of ultrasound on the reperfusion time in an experimental model in vitro. A cylindrical fibrin thrombus with a 2 mm diameter and a 20 microL volume was made by thrombin activation of a pure 0.5% fibrinogen solution in a soft silicone tube. The tube was placed in a low pressure perfusion system and maintained at 37 degrees C. The thrombi were then exposed to hydrostatic loading with a streptokinase concentration of 5000 units/mL. Reperfusion times (RT) were measured from time of Streptokinase exposure to fluid passage, identified by the photoelectric technique. RT increased significantly with increasing thrombus age (r = 0.92, p < 0.05) and was 34-45 min (95% confidence limits) at a thrombus age of 1 h and 102-122 min at a thrombus age of 2 h. RT was unaffected by temperatures between 33 and 45 degrees C but increased with higher temperatures. All investigations of ultrasound effects were performed with 1 h old thrombi and at 37 degrees C. RT decreased by 49% (p < 0.01) as an effect of exposure to 1 MHz ultrasound at 1 W/cm2 SATA. Intermittent ultrasound exposure for 10 microseconds/ms with the same intensity and frequency shortened RT by 54% (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Cardiology, University Hospital, Lund, Sweden.
authors.forename: S B
authors.initials: SB
authors.lastname: Olsson
authors.forename: B
authors.initials: B
authors.lastname: Johansson
authors.forename: A M
authors.initials: AM
authors.lastname: Nilsson
authors.forename: C
authors.initials: C
authors.lastname: Olsson
authors.forename: A
authors.initials: A
authors.lastname: Roijer
mesh_terms: D001775:Blood Circulation / Q000502:physiology; D003131:Combined Modality Therapy; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D008955:Models, Cardiovascular; D015424:Reperfusion; D013300:Streptokinase / Q000627:therapeutic use*; D013696:Temperature; D015912:Thrombolytic Therapy / Q000379:methods*; D013927:Thrombosis / Q000188:drug therapy / Q000473:pathology / Q000628:therapy; D013997:Time Factors; D014159:Transducers; D014464:Ultrasonic Therapy / Q000295:instrumentation / Q000379:methods
chemical_list: D013300:Streptokinase